Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications

SIMPLE SUMMARY: The role of neoadjuvant therapy in pancreatic cancer is poorly defined. Our results show improved overall survival in patients who received neoadjuvant therapy, driven by improved chemotherapy delivery, with no apparent increase in early or late perioperative complications. ABSTRACT:...

Descripción completa

Detalles Bibliográficos
Autores principales: Deig, Christopher Ryan, Sutton, Thomas Lee, Beneville, Blake, Trone, Kristin, Stratton, Amanda, Gunesch, Ali N., Liu, Amy Ivy, Alrohaibani, Alaaeddin, Mohebnasab, Maedeh, Bassale, Solange, Grossblatt-Wait, Alison, Keith, Dove, Attia, Fouad, Gilbert, Erin W., Lopez, Charles D., Kardosh, Adel, Chen, Emerson Y., Bensch, Kenneth G., Nabavizadeh, Nima, Thomas, Charles R., Mayo, Skye C., Sheppard, Brett C., Grossberg, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833799/
https://www.ncbi.nlm.nih.gov/pubmed/35158877
http://dx.doi.org/10.3390/cancers14030609

Ejemplares similares

Ejemplares similares